<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35891317</PMID><DateRevised><Year>2022</Year><Month>07</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-393X</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>7</Issue><PubDate><Year>2022</Year><Month>Jul</Month><Day>20</Day></PubDate></JournalIssue><Title>Vaccines</Title><ISOAbbreviation>Vaccines (Basel)</ISOAbbreviation></Journal><ArticleTitle>Persistent Health Issues, Adverse Events, and Effectiveness of Vaccines during the Second Wave of COVID-19: A Cohort Study from a Tertiary Hospital in North India.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1153</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/vaccines10071153</ELocationID><Abstract><AbstractText><b>Background</b> There is paucity of real-world data on COVID-19 vaccine effectiveness from cohort designs. Variable vaccine performance has been observed in test-negative case-control designs. There is also scarce real-world data of health issues in individuals receiving vaccines after prior COVID-19, and of adverse events of significant concern (AESCs) in the vaccinated. <b>Methods</b>: A cohort study was conducted from July 2021 to December 2021 in a tertiary hospital of North India. The primary outcome was vaccine effectiveness against COVID-19 during the second wave in India. Secondary outcomes were AESCs, and persistent health issues in those receiving COVID-19 vaccines. Regression analyses were performed to determine risk factors of COVID-19 outcomes and persistent health issues. <b>Results</b>: Of the 2760 health care workers included, 2544 had received COVID-19 vaccines, with COVISHIELD (rChAdOx1-nCoV-19 vaccine) received by 2476 (97.3%) and COVAXIN (inactivated SARS-CoV-2 vaccine) by 64 (2.5%). A total of 2691 HCWs were included in the vaccine effectiveness analysis, and 973 COVID-19 events were reported during the period of analysis. Maximum effectiveness of two doses of vaccine in preventing COVID-19 occurrence was 17% across three different strategies of analysis adopted for robustness of data. One-dose recipients were at 1.27-times increased risk of COVID-19. Prior SARS-CoV-2 infection was a strong independent protective factor against COVID-19 (aOR 0.66). Full vaccination reduced moderate-severe COVID-19 by 57%. Those with lung disease were at 2.54-times increased risk of moderate-severe COVID-19, independent of vaccination status. AESCs were observed in 33/2544 (1.3%) vaccinees, including one case each of myocarditis and severe hypersensitivity. Individuals with hypothyroidism were at 5-times higher risk and those receiving a vaccine after recovery from COVID-19 were at 3-times higher risk of persistent health issues. <b>Conclusions</b>: COVID-19 vaccination reduced COVID-19 severity but offered marginal protection against occurrence. The possible relationship of asthma and hypothyroidism with COVID-19 outcomes necessitates focused research. With independent protection of SARS-CoV-2 infection, and high-risk of persistent health issues in individuals receiving vaccine after recovery from SARS-CoV-2 infection, the recommendation of vaccinating those with prior SARS-CoV-2 infection needs reconsideration.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kaur</LastName><ForeName>Upinder</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, UP, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bala</LastName><ForeName>Sapna</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-6171-4507</Identifier><AffiliationInfo><Affiliation>Department of Geriatric Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, UP, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joshi</LastName><ForeName>Aditi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, UP, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reddy</LastName><ForeName>Noti Taruni Srija</ForeName><Initials>NTS</Initials><AffiliationInfo><Affiliation>Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, UP, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Japur</LastName><ForeName>Chetan</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, UP, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chauhan</LastName><ForeName>Mayank</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Kriya Sharir, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, UP, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pedapanga</LastName><ForeName>Nikitha</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Community Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, UP, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Shubham</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, UP, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mukherjee</LastName><ForeName>Anurup</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, UP, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mishra</LastName><ForeName>Vaibhav</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, UP, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Talda</LastName><ForeName>Dolly</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Obstetrics &amp; Gynaecology, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, UP, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Rohit</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Geriatric Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, UP, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gupta</LastName><ForeName>Rohit Kumar</ForeName><Initials>RK</Initials><AffiliationInfo><Affiliation>Department of Geriatric Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, UP, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yadav</LastName><ForeName>Ashish Kumar</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Center for Biostatistics, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, UP, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rana</LastName><ForeName>Poonam Jyoti</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>College of Nursing, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, UP, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Srivastava</LastName><ForeName>Jyoti</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-2303-2019</Identifier><AffiliationInfo><Affiliation>College of Nursing, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, UP, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhat K</LastName><ForeName>Shobha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Agad Tantra, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, UP, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Anup</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-4522-9098</Identifier><AffiliationInfo><Affiliation>Department of Geriatric Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, UP, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>P G</LastName><ForeName>Naveen Kumar</ForeName><Initials>NK</Initials><Identifier Source="ORCID">0000-0002-1972-6413</Identifier><AffiliationInfo><Affiliation>Faculty of Dental Sciences, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, UP, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pandey</LastName><ForeName>Manoj</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-1496-9846</Identifier><AffiliationInfo><Affiliation>Department of Surgical Oncology, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, UP, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patwardhan</LastName><ForeName>Kishor</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-4992-5376</Identifier><AffiliationInfo><Affiliation>Department of Kriya Sharir, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, UP, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kansal</LastName><ForeName>Sangeeta</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Community Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, UP, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chakrabarti</LastName><ForeName>Sankha Shubhra</ForeName><Initials>SS</Initials><Identifier Source="ORCID">0000-0001-7737-0016</Identifier><AffiliationInfo><Affiliation>Department of Geriatric Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, UP, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Vaccines (Basel)</MedlineTA><NlmUniqueID>101629355</NlmUniqueID><ISSNLinking>2076-393X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">RAAS blockers</Keyword><Keyword MajorTopicYN="N">adverse events following immunization</Keyword><Keyword MajorTopicYN="N">asthma</Keyword><Keyword MajorTopicYN="N">hypothyroidism</Keyword><Keyword MajorTopicYN="N">inflammatory arthritis</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">myocarditis</Keyword><Keyword MajorTopicYN="N">pharmacovigilance</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>7</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>27</Day><Hour>1</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>7</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35891317</ArticleId><ArticleId IdType="pmc">PMC9319407</ArticleId><ArticleId IdType="doi">10.3390/vaccines10071153</ArticleId><ArticleId IdType="pii">vaccines10071153</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Polack F.P., Thomas S.J., Kitchin N., Absalon J., Gurtman A., Lockhart S., Perez J.L., P&#xe9;rez Marc G., Moreira E.D., Zerbini C., et al. Safety and Efficacy of the BNT162b2 MRNA Covid-19 Vaccine. N. Engl. J. Med. 2020;383:2603&#x2013;2615. doi: 10.1056/NEJMoa2034577.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2034577</ArticleId><ArticleId IdType="pmc">PMC7745181</ArticleId><ArticleId IdType="pubmed">33301246</ArticleId></ArticleIdList></Reference><Reference><Citation>Baden L.R., El Sahly H.M., Essink B., Kotloff K., Frey S., Novak R., Diemert D., Spector S.A., Rouphael N., Creech C.B., et al. Efficacy and Safety of the MRNA-1273 SARS-CoV-2 Vaccine. N. Engl. J. Med. 2021;384:403&#x2013;416. doi: 10.1056/NEJMoa2035389.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2035389</ArticleId><ArticleId IdType="pmc">PMC7787219</ArticleId><ArticleId IdType="pubmed">33378609</ArticleId></ArticleIdList></Reference><Reference><Citation>Voysey M., Clemens S.A.C., Madhi S.A., Weckx L.Y., Folegatti P.M., Aley P.K., Angus B., Baillie V.L., Barnabas S.L., Bhorat Q.E., et al. Safety and Efficacy of the ChAdOx1 NCoV-19 Vaccine (AZD1222) against SARS-CoV-2: An Interim Analysis of Four Randomised Controlled Trials in Brazil, South Africa, and the UK. Lancet. 2021;397:99&#x2013;111. doi: 10.1016/S0140-6736(20)32661-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32661-1</ArticleId><ArticleId IdType="pmc">PMC7723445</ArticleId><ArticleId IdType="pubmed">33306989</ArticleId></ArticleIdList></Reference><Reference><Citation>Ella R., Reddy S., Blackwelder W., Potdar V., Yadav P., Sarangi V., Aileni V.K., Kanungo S., Rai S., Reddy P., et al. Efficacy, Safety, and Lot-to-Lot Immunogenicity of an Inactivated SARS-CoV-2 Vaccine (BBV152): Interim Results of a Randomised, Double-Blind, Controlled, Phase 3 Trial. Lancet. 2021;398:2173&#x2013;2184. doi: 10.1016/S0140-6736(21)02000-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)02000-6</ArticleId><ArticleId IdType="pmc">PMC8584828</ArticleId><ArticleId IdType="pubmed">34774196</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez Bernal J., Andrews N., Gower C., Robertson C., Stowe J., Tessier E., Simmons R., Cottrell S., Roberts R., O&#x2019;Doherty M., et al. Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca Vaccines on Covid-19 Related Symptoms, Hospital Admissions, and Mortality in Older Adults in England: Test Negative Case-Control Study. BMJ. 2021;373:n1088. doi: 10.1136/bmj.n1088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1088</ArticleId><ArticleId IdType="pmc">PMC8116636</ArticleId><ArticleId IdType="pubmed">33985964</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai D., Khan A.R., Soneja M., Mittal A., Naik S., Kodan P., Mandal A., Maher G.T., Kumar R., Agarwal A., et al. Effectiveness of an Inactivated Virus-Based SARS-CoV-2 Vaccine, BBV152, in India: A Test-Negative, Case-Control Study. Lancet. Infect. Dis. 2022;22:349&#x2013;356. doi: 10.1016/S1473-3099(21)00674-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00674-5</ArticleId><ArticleId IdType="pmc">PMC8610201</ArticleId><ArticleId IdType="pubmed">34826383</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheikh A., McMenamin J., Taylor B., Robertson C. SARS-CoV-2 Delta VOC in Scotland: Demographics, Risk of Hospital Admission, and Vaccine Effectiveness. Lancet. 2021;397:2461&#x2013;2462. doi: 10.1016/S0140-6736(21)01358-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01358-1</ArticleId><ArticleId IdType="pmc">PMC8201647</ArticleId><ArticleId IdType="pubmed">34139198</ArticleId></ArticleIdList></Reference><Reference><Citation>Dean N.E., Hogan J.W., Schnitzer M.E. Covid-19 Vaccine Effectiveness and the Test-Negative Design. N. Engl. J. Med. 2021;385:1431&#x2013;1433. doi: 10.1056/NEJMe2113151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMe2113151</ArticleId><ArticleId IdType="pmc">PMC8451180</ArticleId><ArticleId IdType="pubmed">34496195</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandenbroucke J.P., Pearce N. Test-Negative Designs. Epidemiology. 2019;30:838&#x2013;844. doi: 10.1097/EDE.0000000000001088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EDE.0000000000001088</ArticleId><ArticleId IdType="pubmed">31430265</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilishvili T., Gierke R., Fleming-Dutra K.E., Farrar J.L., Mohr N.M., Talan D.A., Krishnadasan A., Harland K.K., Smithline H.A., Hou P.C., et al. Effectiveness of MRNA Covid-19 Vaccine among U.S. Health Care Personnel. N. Engl. J. Med. 2021;385:e90. doi: 10.1056/NEJMoa2106599.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2106599</ArticleId><ArticleId IdType="pmc">PMC8482809</ArticleId><ArticleId IdType="pubmed">34551224</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (WHO) Evaluation of COVID-19 Vaccine Effectiveness. WHO; Geneva, Switzerland: 2021. 70p Interim Guidance.</Citation></Reference><Reference><Citation>Montgomery J., Ryan M., Engler R., Hoffman D., McClenathan B., Collins L., Loran D., Hrncir D., Herring K., Platzer M., et al. Myocarditis Following Immunization with MRNA COVID-19 Vaccines in Members of the US Military. JAMA Cardiol. 2021;6:1202&#x2013;1206. doi: 10.1001/jamacardio.2021.2833.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2021.2833</ArticleId><ArticleId IdType="pmc">PMC8243257</ArticleId><ArticleId IdType="pubmed">34185045</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh R., Chakrabarti S.S., Gambhir I.S., Verma A., Kumar I., Ghosh S., Tiwari A., Chandan G., Chakrabarti S., Kaur U. Acute Cardiac Events after ChAdOx1 NCoV-19 Corona Virus Vaccine. Am. J. Ther. 2022 doi: 10.1097/MJT.0000000000001472.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MJT.0000000000001472</ArticleId><ArticleId IdType="pubmed">35175717</ArticleId></ArticleIdList></Reference><Reference><Citation>Tagini F., Carrel L., Fallet B., Gachoud D., Ribi C., Monti M. Beh&#xe7;et&#x2019;s-like Adverse Event or Inaugural Beh&#xe7;et&#x2019;s Disease after SARS-CoV-2 MRNA-1273 Vaccination? Rheumatology. 2022;61:e112&#x2013;e113. doi: 10.1093/rheumatology/keab751.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keab751</ArticleId><ArticleId IdType="pmc">PMC8522430</ArticleId><ArticleId IdType="pubmed">34617989</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur U., Ojha B., Pathak B.K., Singh A., Giri K.R., Singh A., Das A., Misra A., Yadav A.K., Kansal S., et al. A Prospective Observational Safety Study on ChAdOx1 NCoV-19 Corona Virus Vaccine (Recombinant) Use in Healthcare Workers- First Results from India. eClinicalMedicine. 2021;38:101038. doi: 10.1016/j.eclinm.2021.101038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101038</ArticleId><ArticleId IdType="pmc">PMC8413251</ArticleId><ArticleId IdType="pubmed">34505032</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur U., Bala S., Ojha B., Jaiswal S., Kansal S., Chakrabarti S.S. Occurrence of COVID-19 in Priority Groups Receiving ChAdOx1 NCoV-19 Coronavirus Vaccine (Recombinant): A Preliminary Analysis from North India. J. Med. Virol. 2022;94:407&#x2013;412. doi: 10.1002/jmv.27320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27320</ArticleId><ArticleId IdType="pmc">PMC8662184</ArticleId><ArticleId IdType="pubmed">34491572</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Wang J., Xu J., Xia H., Wang Y., Zhang C., Chen W., Zhang H., Liu Q., Zhu R., et al. Comprehensive Investigations Revealed Consistent Pathophysiological Alterations after Vaccination with COVID-19 Vaccines. Cell Discov. 2021;7:99. doi: 10.1038/s41421-021-00329-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41421-021-00329-3</ArticleId><ArticleId IdType="pmc">PMC8546144</ArticleId><ArticleId IdType="pubmed">34697287</ArticleId></ArticleIdList></Reference><Reference><Citation>Voysey M., Costa Clemens S.A., Madhi S.A., Weckx L.Y., Folegatti P.M., Aley P.K., Angus B., Baillie V.L., Barnabas S.L., Bhorat Q.E., et al. Single-Dose Administration and the Influence of the Timing of the Booster Dose on Immunogenicity and Efficacy of ChAdOx1 NCoV-19 (AZD1222) Vaccine: A Pooled Analysis of Four Randomised Trials. Lancet. 2021;397:881&#x2013;891. doi: 10.1016/S0140-6736(21)00432-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00432-3</ArticleId><ArticleId IdType="pmc">PMC7894131</ArticleId><ArticleId IdType="pubmed">33617777</ArticleId></ArticleIdList></Reference><Reference><Citation>Victor P.J., Mathews K.P., Paul H., Murugesan M., Mammen J.J. Protective Effect of COVID-19 Vaccine Among Health Care Workers During the Second Wave of the Pandemic in India. Mayo Clin. Proc. 2021;96:2493&#x2013;2494. doi: 10.1016/j.mayocp.2021.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2021.06.003</ArticleId><ArticleId IdType="pmc">PMC8233962</ArticleId><ArticleId IdType="pubmed">34366135</ArticleId></ArticleIdList></Reference><Reference><Citation>Satwik R., Satwik A., Katoch S., Saluja S. ChAdOx1 NCoV-19 Effectiveness during an Unprecedented Surge in SARS COV-2 Infections. Eur. J. Intern. Med. 2021;93:112&#x2013;113. doi: 10.1016/j.ejim.2021.08.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2021.08.005</ArticleId><ArticleId IdType="pmc">PMC8364816</ArticleId><ArticleId IdType="pubmed">34419309</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur U., Bala S., Ojha B., Pathak B.K., Joshi A., Yadav A.K., Singh A., Kansal S. Patterns and Predictors of COVID-19 Occurrence and Severity in Vaccinated Priority Groups. Res. Sq. 2021 doi: 10.21203/rs.3.rs-1204671/v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-1204671/v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Onder G., Rezza G., Brusaferro S. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. JAMA. 2020;323:1775&#x2013;1776. doi: 10.1001/jama.2020.4683.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.4683</ArticleId><ArticleId IdType="pubmed">32203977</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson E.J., Walker A.J., Bhaskaran K., Bacon S., Bates C., Morton C.E., Curtis H.J., Mehrkar A., Evans D., Inglesby P., et al. Factors Associated with COVID-19-Related Death Using OpenSAFELY. Nature. 2020;584:430&#x2013;436. doi: 10.1038/s41586-020-2521-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2521-4</ArticleId><ArticleId IdType="pmc">PMC7611074</ArticleId><ArticleId IdType="pubmed">32640463</ArticleId></ArticleIdList></Reference><Reference><Citation>Mu&#xf1;oz X., Pilia F., Ojanguren I., Romero-Mesones C., Cruz M.-J. Is Asthma a Risk Factor for COVID-19? Are Phenotypes Important? ERJ Open Res. 2021;7:00216&#x2013;02020. doi: 10.1183/23120541.00216-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00216-2020</ArticleId><ArticleId IdType="pmc">PMC7667724</ArticleId><ArticleId IdType="pubmed">33527078</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Zhong X., Wang Y., Zeng X., Luo T., Liu Q. Clinical Determinants of the Severity of COVID-19: A Systematic Review and Meta-Analysis. PLoS ONE. 2021;16:e0250602. doi: 10.1371/journal.pone.0250602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0250602</ArticleId><ArticleId IdType="pmc">PMC8092779</ArticleId><ArticleId IdType="pubmed">33939733</ArticleId></ArticleIdList></Reference><Reference><Citation>Gall&#xe8; F., Sabella E.A., Roma P., Ferracuti S., Da Molin G., Diella G., Montagna M.T., Orsi G.B., Liguori G., Napoli C. Knowledge and Lifestyle Behaviors Related to COVID-19 Pandemic in People over 65 Years Old from Southern Italy. Int. J. Environ. Res. Public Health. 2021;18:10872. doi: 10.3390/ijerph182010872.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph182010872</ArticleId><ArticleId IdType="pmc">PMC8535846</ArticleId><ArticleId IdType="pubmed">34682618</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>